UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

A randomized, controlled trial comparing ganciclovir or ganciclovir plus foscarnet (each at half dose) for pre-emptive therapy of cytomegalovirus infection in transplant recipients.

Prentice, HG; Potter, MN; Mattes, FM; Hainsworth, E; Murdin-Geretti, A; Nebbia, G; ... Griffiths, PD; + view all (2001) A randomized, controlled trial comparing ganciclovir or ganciclovir plus foscarnet (each at half dose) for pre-emptive therapy of cytomegalovirus infection in transplant recipients. BLOOD , 98 (11) 395A - 395A.

Full text not available from this repository.


Type:Article
Title:A randomized, controlled trial comparing ganciclovir or ganciclovir plus foscarnet (each at half dose) for pre-emptive therapy of cytomegalovirus infection in transplant recipients.
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Infection and Immunity (Division of) > Research Department of Infection

Archive Staff Only: edit this record